INTRODUCTION
The survival of gastric cancer has steadily improved in the past decade along with advanced diagnostics and screening programs and improvement of chemotherapy.
However, the prognosis of unresectable gastric cancer is still poor, with peritoneal seeding, distant metastasis, and distant lymph node metastasis.
Para-aortic lymph node (PAN) metastasis is considered a distant lymph node metastasis. The prognosis of gastric cancer with PAN metastasis is quite poor even after prophylactic para-aortic lymphadenectomy [1] . For this reason, systemic chemotherapy is commonly preferred as a primary mode of treatment in these patients. Various kinds of chemotherapeutic regiments including 5-fluorouracil, cisplatin, irinotecan, taxans, and capecitabine Stage: 7th edition tumor-node-metastasis classification system by the American Joint Committee on Cancer. Recently several cases of therapeutic gastrectomy with para-aortic lymphadenectomy after chemotherapy were reported [2] [3] [4] , but the efficacy of gastrectomy with para-aortic lymphadenectomy after chemotherapy remains still unclear.
Laparoscopy-assisted gastrectomy is an option in the treatment of gastric cancer, and the indication for this procedure has extended to locally advanced gastric cancer.
However, there was no report of laparoscopic para-aortic lymphadenectomy in gastric cancer except laparoscopic biopsy of PAN for the staging [5] . Herein, we report three cases of laparoscopy-assisted gastrectomy with para-aortic lymphadenectomy after palliative chemotherapy for far advanced gastric cancer for the first time in Korea.
CASE REPORTS
The details of three cases are summarized in Table 1 .
Case 1
A 45 year-old man was diagnosed with a poorly differ- He was discharged at 8 days postoperatively without any complications.
Laparoscopic para-aortic lymphadenectomy
All laparoscopic para-aortic lymphadenectomies were performed with the standard 5-port system used in laparoscopy-assisted total gastrectomy without any additional port insertion (Fig. 1 ). An ultrasonic cutting device (SonoSurg, Olympus, Tokyo, Japan) and LigaSure (Valleylab, Boulder, CO, USA) was used to minimize postoperative bleeding and ascites after lymphadenectomy.
After laparoscopy-assisted subtotal or total gastrectomy with complete omentectomy and D2 lymphadenectomy, PAN dissection proceeded from 16b1 area to 16a2
area. The infra-pancreas mesocolon was first dissected to 
DISCUSSION
In advanced gastric cancer, the prevalence of microscopic metastases in the para-aortic region is 10% to 30% [6, 7] . Because the 5-year overall survival rate of patients with PAN metastases is less than 20% even after prophylactic dissection, D2 lymphadenectomy plus PAN dissection is not recommended in curable gastric cancer [1] .
PAN involvement is now considered M1 in tumornode-metastasis (TNM) classification system (7th edition)
as reported by the American Joint Committee on Cancer.
In unresectable gastric cancer, the isolated PAN metastasis seems to be different from other metastasis. Park et al. [8] reported that PAN-only metastasis showed better survival and longer time to other organ metastasis com- In conclusion, laparoscopic para-aortic lymphadenectomy in gastric cancer was feasible in terms of technique.
However a multi-institutional clinical phase II study is needed to quantify the short-term benefit and long-term oncologic outcome of laparoscopy-assisted gastrectomy with para-aortic lymphadenectomy after chemotherapy for advanced gastric cancer with isolated PAN metastasis.
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